{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T06:20:49Z","timestamp":1782022849143,"version":"3.54.5"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Thailand Science Research and Innovation (TSRI) under the Ministry of Higher Education, Science, Research and Innovation of Thailand","award":["\u0e3aBRF1-007\/2565"],"award-info":[{"award-number":["\u0e3aBRF1-007\/2565"]}]},{"name":"The Graduate Scholarship Program of the Faculty of Medical Technology, Mahidol University, Thailand"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Tuberculosis (TB) caused by <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (Mtb) poses a major threat to the global public health. Importantly, latent tuberculosis infection (LTBI) still impedes the elimination of TB incidence since it has a substantial risk to develop active disease. A multi-stage subunit vaccine comprising active and latency antigens of Mtb has been raised as the promising vaccine to trigger immune protection against all stages of TB. Therefore, the discovery of new antigens that could trigger broad immune response is essential. While current development of TB vaccine mainly focuses on protective immunity mediated by adaptive immune response, the knowledge on triggering the innate immune response by antigens is still limited. We showed that recombinant dormancy-associated Mtb proteins Rv2659c and Rv1738 were recognized by human innate immune recognition molecules, Toll-like receptors (TLRs) 2 and 4 by using HEK-Blue\u2122 hTLR2\/hTLR4 systems. We further demonstrated that these two proteins activated phosphorylated NF-\u03baB p65 (Ser536) in the human CD14<jats:sup>+<\/jats:sup> blood cells. We also investigated that these two proteins significantly induced level of pro- and anti-inflammatory cytokines (IL-1\u03b2, IL-6, IL-8, IL-10 and TNF-\u03b1) which were mediated through TLR2 and TLR4 pathways in human peripheral blood mononuclear cells (hPBMCs). These findings suggest that proteins Rv2659c and Rv1738 stimulated innate immune response targeting TLR2 and TLR4 to produce inflammatory cytokines, and their benefits would be valuable for the development of an effective prophylactic tuberculosis vaccine.<\/jats:p>","DOI":"10.1371\/journal.pone.0273517","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T18:01:04Z","timestamp":1662055264000},"page":"e0273517","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738"],"prefix":"10.1371","volume":"17","author":[{"given":"Chutiphon","family":"Saelee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jariya","family":"Hanthamrongwit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyu Thwe","family":"Soe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasong","family":"Khaenam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naharuthai","family":"Inthasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattama","family":"Ekpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patchanee","family":"Chootong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2390-3048","authenticated-orcid":true,"given":"Chaniya","family":"Leepiyasakulchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"pone.0273517.ref001","volume-title":"Global tuberculosis report 2021","author":"WHO","year":"2021"},{"issue":"3","key":"pone.0273517.ref002","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1378\/chest.12-0142","article-title":"Relevance of latent TB infection in areas of high TB prevalence.","volume":"142","author":"SK Sharma","year":"2012","journal-title":"Chest"},{"key":"pone.0273517.ref003","volume-title":"Implementing the end TB strategy: the essentials.","author":"WHO","year":"2015"},{"issue":"1","key":"pone.0273517.ref004","article-title":"After 100 Years of BCG Immunization against Tuberculosis, What Is New and Still Outstanding for This Vaccine?","volume":"10","author":"MA Flores-Valdez","year":"2021","journal-title":"Vaccines (Basel)."},{"issue":"3","key":"pone.0273517.ref005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MRM.0000000000000213","article-title":"Overview of multistage subunit tuberculosis vaccines: advantages and challenges","volume":"31","author":"M Keikha","year":"2020","journal-title":"Reviews in Medical Microbiology"},{"key":"pone.0273517.ref006","article-title":"Clinical development of new TB vaccines: recent advances and next steps.","volume":"3154","author":"M Hatherill","year":"2020","journal-title":"Frontiers in microbiology"},{"issue":"1","key":"pone.0273517.ref007","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"PL Lin","year":"2012","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"pone.0273517.ref008","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14760584.2018.1406309","article-title":"Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?","volume":"17","author":"F Khademi","year":"2017","journal-title":"Expert Review of Vaccines."},{"issue":"19","key":"pone.0273517.ref009","doi-asserted-by":"crossref","DOI":"10.3390\/app11199250","article-title":"Tuberculosis Vaccines: An Update of Recent and Ongoing Clinical Trials.","volume":"11","author":"S Saramago","year":"2021","journal-title":"Applied Sciences"},{"key":"pone.0273517.ref010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fimmu.2017.00084","article-title":"Mycobacterial Dormancy Systems and Host Responses in Tuberculosis.","volume":"8","author":"V Peddireddy","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0273517.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.24302","article-title":"The Mycobacterium DosR regulon structure and diversity revealed by comparative genomic analysis","volume":"114","author":"T Chen","year":"2013","journal-title":"J Cell Biochem"},{"issue":"2","key":"pone.0273517.ref012","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/hgtb.2018.211","article-title":"Immunogenicity and therapeutic effects of latency-associated genes in a Mycobacterium tuberculosis reactivation mouse model","volume":"30","author":"Y Liang","year":"2019","journal-title":"Human Gene Therapy Methods"},{"issue":"2","key":"pone.0273517.ref013","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/IAI.01137-06","article-title":"Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice","volume":"75","author":"V Roupie","year":"2007","journal-title":"Infection and immunity"},{"key":"pone.0273517.ref014","first-page":"517","article-title":"Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis.","volume":"5","author":"MM Serra-Vidal","year":"2014","journal-title":"Frontiers in microbiology"},{"issue":"8","key":"pone.0273517.ref015","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7080255","article-title":"Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity.","volume":"7","author":"E Stewart","year":"2019","journal-title":"Microorganisms"},{"issue":"1","key":"pone.0273517.ref016","doi-asserted-by":"crossref","first-page":"e83884","DOI":"10.1371\/journal.pone.0083884","article-title":"A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93.","volume":"9","author":"MT Orr","year":"2014","journal-title":"PLoS One."},{"key":"pone.0273517.ref017","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3389\/fimmu.2019.01144","article-title":"Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.","volume":"10","author":"S Kumar","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"pone.0273517.ref018","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","article-title":"Translating innate immunity into immunological memory: implications for vaccine development","volume":"124","author":"B Pulendran","year":"2006","journal-title":"Cell"},{"issue":"1","key":"pone.0273517.ref019","doi-asserted-by":"crossref","first-page":"e16097","DOI":"10.1371\/journal.pone.0016097","article-title":"Co-administration of IL-1+IL-6+TNF-alpha with Mycobacterium tuberculosis infected macrophages vaccine induces better protective T cell memory than BCG","volume":"6","author":"V Singh","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"pone.0273517.ref020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/intimm\/dxq459","article-title":"TLR2 deficiency by compromising p19 (IL-23) expression limits Th 17 cell responses to Mycobacterium tuberculosis.","volume":"23","author":"M Teixeira-Coelho","year":"2011","journal-title":"International immunology"},{"key":"pone.0273517.ref021","first-page":"2015","article-title":"Binding of CXCL8\/IL-8 to Mycobacterium tuberculosis modulates the innate immune response","author":"A Krupa","year":"2015","journal-title":"Mediators of inflammation"},{"key":"pone.0273517.ref022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2015.11.012","article-title":"Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates","volume":"102","author":"EM Agger","year":"2016","journal-title":"Advanced drug delivery reviews"},{"issue":"14","key":"pone.0273517.ref023","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1073\/pnas.1422387112","article-title":"A functional role of Rv1738 in Mycobacterium tuberculosis persistence suggested by racemic protein crystallography","volume":"112","author":"RD Bunker","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"pone.0273517.ref024","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/07391102.2015.1022602","article-title":"Distribution and function of prophage phiRv1 and phiRv2 among Mycobacterium tuberculosis complex","volume":"34","author":"X Fan","year":"2016","journal-title":"J Biomol Struct Dyn"},{"key":"pone.0273517.ref025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijid.2021.07.033","article-title":"Circulating IgA\/IgG memory B cells against Mycobacterium tuberculosis dormancy-associated antigens Rv2659c and Rv3128c in active and latent tuberculosis.","volume":"110","author":"PT Soe","year":"2021","journal-title":"International Journal of Infectious Diseases."},{"issue":"1","key":"pone.0273517.ref026","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.vaccine.2010.10.022","article-title":"Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease","volume":"29","author":"L Govender","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"pone.0273517.ref027","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1021\/acsinfecdis.9b00329","article-title":"Use of DosR dormancy antigens from Mycobacterium tuberculosis for serodiagnosis of active and latent tuberculosis","volume":"6","author":"S-D Shi","year":"2019","journal-title":"ACS Infectious Diseases"},{"issue":"6","key":"pone.0273517.ref028","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/sji.12556","article-title":"Subunit Vaccines Consisting of Antigens from Dormant and Replicating Bacteria Show Promising Therapeutic Effect against Mycobacterium Bovis BCG Latent Infection","volume":"85","author":"F Li","year":"2017","journal-title":"Scand J Immunol"},{"key":"pone.0273517.ref029","first-page":"011","article-title":"High Temperature Affects Cytokine Release by Human Peripheral Blood Mononuclear Cells.","volume":"2","author":"DM Bessler H","year":"2015","journal-title":"Int J Immunol Immunother"},{"key":"pone.0273517.ref030","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/697972","article-title":"Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide.","volume":"2013","author":"A Schildberger","year":"2013","journal-title":"Mediators of inflammation."},{"issue":"5","key":"pone.0273517.ref031","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/20477724.2017.1351080","article-title":"New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection","volume":"111","author":"M Faridgohar","year":"2017","journal-title":"Pathog Glob Health"},{"issue":"4","key":"pone.0273517.ref032","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1189\/jlb.0912435","article-title":"Mycobacterium tuberculosis RpfB drives Th1\u2010type T cell immunity via a TLR4\u2010dependent activation of dendritic cells","volume":"94","author":"JS Kim","year":"2013","journal-title":"Journal of leukocyte biology"},{"issue":"3","key":"pone.0273517.ref033","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/00365548.2014.982167","article-title":"Latency-associated protein Rv2660c of Mycobacterium tuberculosis augments expression of proinflammatory cytokines in human macrophages by interacting with TLR2.","volume":"47","author":"D Yihao","year":"2015","journal-title":"Infectious Diseases."},{"key":"pone.0273517.ref034","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"T Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"pone.0273517.ref035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-36052-5","article-title":"Elevated pre-activation basal level of nuclear NF-\u03baB in native macrophages accelerates LPS-induced translocation of cytosolic NF-\u03baB into the cell nucleus","volume":"9","author":"AV Bagaev","year":"2019","journal-title":"Scientific reports"},{"issue":"1","key":"pone.0273517.ref036","first-page":"1","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study.","volume":"5","author":"H Yu","year":"2020","journal-title":"Signal transduction and targeted therapy."},{"issue":"4","key":"pone.0273517.ref037","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"A Iwasaki","year":"2015","journal-title":"Nature immunology"},{"issue":"8","key":"pone.0273517.ref038","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.4049\/jimmunol.175.8.5043","article-title":"Rapid production of TNF-\u03b1 following TCR engagement of naive CD8 T cells","volume":"175","author":"MA Brehm","year":"2005","journal-title":"The Journal of Immunology"},{"issue":"1","key":"pone.0273517.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-021-00812-0","article-title":"Scavenger receptors in host defense: from functional aspects to mode of action","volume":"20","author":"Q Taban","year":"2022","journal-title":"Cell Communication and Signaling"},{"issue":"1","key":"pone.0273517.ref040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12274","article-title":"T cells and adaptive immunity to Mycobacterium tuberculosis in humans","volume":"264","author":"LD Jasenosky","year":"2015","journal-title":"Immunological reviews"},{"issue":"1","key":"pone.0273517.ref041","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000494463","article-title":"The role of toll-like receptors in the production of cytokines by human lung macrophages","volume":"12","author":"S Grassin-Delyle","year":"2020","journal-title":"Journal of innate immunity"},{"key":"pone.0273517.ref042","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.coi.2016.06.003","article-title":"Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the question","volume":"42","author":"A Gopalakrishnan","year":"2016","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"pone.0273517.ref043","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/biology11020246","article-title":"The role of TLR2 in infectious diseases caused by mycobacteria: from cell biology to therapeutic target","volume":"11","author":"W Hu","year":"2022","journal-title":"Biology"},{"issue":"6","key":"pone.0273517.ref044","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1096\/fj.11-199588","article-title":"Mycobacterium tuberculosis Rv0577, a novel TLR2 agonist, induces maturation of dendritic cells and drives Th1 immune response","volume":"26","author":"EH Byun","year":"2012","journal-title":"The FASEB Journal"},{"issue":"18","key":"pone.0273517.ref045","doi-asserted-by":"crossref","first-page":"24962","DOI":"10.18632\/oncotarget.8771","article-title":"Mycobacterium tuberculosis Rv3628 drives Th1-type T cell immunity via TLR2-mediated activation of dendritic cells and displays vaccine potential against the hyper-virulent Beijing K strain.","volume":"7","author":"WS Kim","year":"2016","journal-title":"Oncotarget."},{"issue":"1","key":"pone.0273517.ref046","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/21505594.2020.1766401","article-title":"Toll-like receptor 4 signaling-mediated responses are critically engaged in optimal host protection against highly virulent Mycobacterium tuberculosis K infection.","volume":"11","author":"J Park","year":"2020","journal-title":"Virulence"},{"issue":"3","key":"pone.0273517.ref047","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000439591","article-title":"NOD-2 and TLR-4 Signaling Reinforces the Efficacy of Dendritic Cells and Reduces the Dose of TB Drugs against Mycobacterium tuberculosis","volume":"8","author":"N Khan","year":"2016","journal-title":"J Innate Immun"},{"issue":"1","key":"pone.0273517.ref048","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12890-017-0517-0","article-title":"TLR4-NOX2 axis regulates the phagocytosis and killing of Mycobacterium tuberculosis by macrophages","volume":"17","author":"J Lv","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"1","key":"pone.0273517.ref049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2199-8-64","article-title":"A flow cytometry technique to study intracellular signals NF-\u03baB and STAT3 in peripheral blood mononuclear cells","volume":"8","author":"S Lafarge","year":"2007","journal-title":"BMC Molecular Biology"},{"issue":"21","key":"pone.0273517.ref050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215351","article-title":"Monitoring the Levels of Cellular NF-kappaB Activation States.","volume":"13","author":"J Meier-Soelch","year":"2021","journal-title":"Cancers (Basel)."},{"key":"pone.0273517.ref051","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/179174","article-title":"Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection\u2014the double-edged sword?","volume":"2013","author":"M Hossain","year":"2013","journal-title":"BioMed research international."},{"issue":"6","key":"pone.0273517.ref052","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.4049\/jimmunol.171.6.3110","article-title":"Reactivation of latent tuberculosis infection in TNF-deficient mice","volume":"171","author":"T Botha","year":"2003","journal-title":"J Immunol"},{"issue":"1","key":"pone.0273517.ref053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04146.x","article-title":"How tumour necrosis factor blockers interfere with tuberculosis immunity","volume":"161","author":"J Harris","year":"2010","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"pone.0273517.ref054","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1086\/315771","article-title":"Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis","volume":"182","author":"NP Juffermans","year":"2000","journal-title":"The Journal of infectious diseases"},{"key":"pone.0273517.ref055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fimmu.2016.00465","article-title":"IL-1\u03b2, but not programed death-1 and programed death ligand pathway, is critical for the human Th17 response to Mycobacterium tuberculosis.","volume":"7","author":"E Stephen-Victor","year":"2016","journal-title":"Frontiers in immunology"},{"issue":"1","key":"pone.0273517.ref056","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clim.2008.08.018","article-title":"The effects of IL-6 on CD4 T cell responses","volume":"130","author":"O Dienz","year":"2009","journal-title":"Clin Immunol"},{"issue":"9","key":"pone.0273517.ref057","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.4049\/jimmunol.171.9.4750","article-title":"Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-\u03b3","volume":"171","author":"V Nagabhushanam","year":"2003","journal-title":"The Journal of Immunology"},{"issue":"6","key":"pone.0273517.ref058","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/IAI.68.6.3322-3326.2000","article-title":"Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection","volume":"68","author":"BM Saunders","year":"2000","journal-title":"Infection and immunity"},{"issue":"1","key":"pone.0273517.ref059","doi-asserted-by":"crossref","first-page":"e16333","DOI":"10.1371\/journal.pone.0016333","article-title":"Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant","volume":"6","author":"RN Coler","year":"2011","journal-title":"PloS one"},{"issue":"3","key":"pone.0273517.ref060","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1473-3099(19)30625-5","article-title":"The status of tuberculosis vaccine development","volume":"20","author":"LK Schrager","year":"2020","journal-title":"The Lancet Infectious Diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0273517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T18:02:17Z","timestamp":1662055337000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0273517"}},"subtitle":[],"editor":[{"given":"Selvakumar","family":"Subbian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":60,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0273517","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]}}}